Search research articles
Contact Us
Filters
Showing results (71-80 of 183) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2000
Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein
H A Bardelmeijer, J H Beijnen, K R Brouwer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 29, 2019
Development and validation of an LC-MS/MS method with a broad linear dynamic range for the quantification of tivozanib in human and mouse plasma, mouse tissue homogenates, and culture medium
M A C Bruin, H Rosing, L Lucas, et al.
Biomedical Chromatography : BMC
|
November 23, 2017
Development and validation of a liquid chromatography-tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs
M Herbrink, N de Vries, H Rosing, et al.
Journal of Mass Spectrometry : JMS
|
December 4, 2004
A simple and sensitive assay for the quantitative analysis of paclitaxel in human and mouse plasma and brain tumor tissue using coupled liquid chromatography and tandem mass spectrometry
E Stokvis, M Ouwehand, L G A H Nan, et al.
Journal of Mass Spectrometry : JMS
|
March 25, 2004
Quantitative analysis of the novel anticancer drug ABT-518, a matrix metalloproteinase inhibitor, plus the screening of six metabolites in human plasma using high-performance liquid chromatography coupled with electrospray tandem mass spectrometry
E Stokvis, H Rosing, M Crul, et al.
Cancer Chemotherapy and Pharmacology
|
January 6, 2007
Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours
S A Veltkamp, H Rosing, A D R Huitema, et al.
British Journal of Cancer
|
May 1, 1996
Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor
J H Schellens, G J Creemers, J H Beijnen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1995
Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial
M T Huizing, J B Vermorken, H Rosing, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 30, 2017
Liquid chromatography-tandem mass spectrometry assay to quantify plitidepsin in human plasma, whole blood and urine
L van Andel, H Rosing, S Fudio, et al.
Rapid Communications in Mass Spectrometry : RCM
|
November 16, 2005
Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
L H H Silvertand, F Vazvaei, P Weigl, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 183) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2000
Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein
H A Bardelmeijer, J H Beijnen, K R Brouwer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 29, 2019
Development and validation of an LC-MS/MS method with a broad linear dynamic range for the quantification of tivozanib in human and mouse plasma, mouse tissue homogenates, and culture medium
M A C Bruin, H Rosing, L Lucas, et al.
Biomedical Chromatography : BMC
|
November 23, 2017
Development and validation of a liquid chromatography-tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs
M Herbrink, N de Vries, H Rosing, et al.
Journal of Mass Spectrometry : JMS
|
December 4, 2004
A simple and sensitive assay for the quantitative analysis of paclitaxel in human and mouse plasma and brain tumor tissue using coupled liquid chromatography and tandem mass spectrometry
E Stokvis, M Ouwehand, L G A H Nan, et al.
Journal of Mass Spectrometry : JMS
|
March 25, 2004
Quantitative analysis of the novel anticancer drug ABT-518, a matrix metalloproteinase inhibitor, plus the screening of six metabolites in human plasma using high-performance liquid chromatography coupled with electrospray tandem mass spectrometry
E Stokvis, H Rosing, M Crul, et al.
Cancer Chemotherapy and Pharmacology
|
January 6, 2007
Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours
S A Veltkamp, H Rosing, A D R Huitema, et al.
British Journal of Cancer
|
May 1, 1996
Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor
J H Schellens, G J Creemers, J H Beijnen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1995
Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial
M T Huizing, J B Vermorken, H Rosing, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 30, 2017
Liquid chromatography-tandem mass spectrometry assay to quantify plitidepsin in human plasma, whole blood and urine
L van Andel, H Rosing, S Fudio, et al.
Rapid Communications in Mass Spectrometry : RCM
|
November 16, 2005
Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
L H H Silvertand, F Vazvaei, P Weigl, et al.
Page
of 19